Literature DB >> 28965253

Dietary Peptides from Phaseolus vulgaris L. Reduced AOM/DSS-Induced Colitis-Associated Colon Carcinogenesis in Balb/c Mice.

Diego A Luna-Vital1,2, Elvira González de Mejía2, Guadalupe Loarca-Piña3.   

Abstract

The aim was to evaluate the antineoplastic potential of a previously characterized peptide extract from the non-digestible fraction of common bean cv. Azufrado Higuera (AH) and its most abundant pure peptide GLTSK, in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced colitis-associated colon carcinogenesis Balb/c mice model. The healthy control (C-) had no induction and no treatment, and the induced control (C+) had induction but no treatment. Groups AH and GLTSK were administered 50 mg/kg-bw of AH or GLTSK, respectively. The administration of AH and GLTSK decreased (p < 0.05) the disease activity index (DAI) compared to C+ (5.8, 9.1, 11.8, respectively). Furthermore, AH reduced the number of evident neoplasms compared to group C+ (1.8, 5.9 neoplasms/mice, respectively). The results suggest that peptides from common bean cv. Azufrado Higuera could prevent colitis-associated colon carcinogenesis.

Entities:  

Keywords:  Anticancer peptides; Bioactive peptides; Colon carcinogenesis; Common bean

Mesh:

Substances:

Year:  2017        PMID: 28965253     DOI: 10.1007/s11130-017-0633-2

Source DB:  PubMed          Journal:  Plant Foods Hum Nutr        ISSN: 0921-9668            Impact factor:   3.921


  6 in total

1.  Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.

Authors:  Rikako Suzuki; Hiroyuki Kohno; Shigeyuki Sugie; Hitoshi Nakagama; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2005-08-04       Impact factor: 4.944

2.  Dietary peptides from the non-digestible fraction of Phaseolus vulgaris L. decrease angiotensin II-dependent proliferation in HCT116 human colorectal cancer cells through the blockade of the renin-angiotensin system.

Authors:  Diego A Luna-Vital; Katie Liang; Elvira González de Mejía; Guadalupe Loarca-Piña
Journal:  Food Funct       Date:  2016-05-09       Impact factor: 5.396

3.  Peptides in common bean fractions inhibit human colorectal cancer cells.

Authors:  Diego A Luna Vital; Elvira González de Mejía; Vermont P Dia; Guadalupe Loarca-Piña
Journal:  Food Chem       Date:  2014-02-21       Impact factor: 7.514

4.  The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome.

Authors:  X-Y Li; J-F Sun; S-Q Hu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-03       Impact factor: 3.507

Review 5.  Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.

Authors:  Mathurin Fumery; Parambir S Dulai; Samir Gupta; Larry J Prokop; Sonia Ramamoorthy; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-01       Impact factor: 11.382

6.  Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.

Authors:  Xiao-dong Peng; Xiao-hua Wu; Li-juan Chen; Zhen-ling Wang; Xiao-hong Hu; Li-fang Song; Chun-mei He; You-fu Luo; Zhi-zhi Chen; Ke Jin; Hong-gang Lin; Xiao-lei Li; Yong-sheng Wang; Yu-quan Wei
Journal:  J Pharmacol Exp Ther       Date:  2009-10-14       Impact factor: 4.030

  6 in total
  2 in total

Review 1.  The Potential of Food Protein-Derived Bioactive Peptides against Chronic Intestinal Inflammation.

Authors:  Wanying Zhu; Liying Ren; Li Zhang; Qinqin Qiao; Muhammad Zahid Farooq; Qingbiao Xu
Journal:  Mediators Inflamm       Date:  2020-09-09       Impact factor: 4.711

2.  Modification of In Vitro and In Vivo Antioxidant Activity by Consumption of Cooked Chickpea in a Colon Cancer Model.

Authors:  María S Cid-Gallegos; Xariss M Sánchez-Chino; Isela Álvarez-González; Eduardo Madrigal-Bujaidar; Verónica R Vásquez-Garzón; Rafael Baltiérrez-Hoyos; Saúl Villa-Treviño; Gloria Dávila-Ortíz; Cristian Jiménez-Martínez
Journal:  Nutrients       Date:  2020-08-25       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.